Skip to main content

Table 3 HE4 concentrations in serum, peritoneal fluid and tumor/cyst fluid and CA125 concentrations in serum in examined subgroups of group II

From: HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

 

HE4-peritoneal fluid [pmol/L]

HE4- serum [pmol/L]

CA125- serum [mIU/ml]

HE4 –tumor/cyst fluid [pmol/L]

Functional cysts

1799

52.6

17.3

2097

[median/95% CI]

[-1152.67-4750.66]

[19.53-85.67]

[5.54-29.07]

[-1208.38-5402.38]

Endometrial cysts

5248

45.05

56.6

15674

[median/95% CI]

[-2563.74-13059.74]

[31.66-58.44]

[7.89-105.32]

[-27785.5-59133.53]

Mature teratoma

405.3

47.65

30.15

384.3

[median/95% CI]

[3.13-807.47]

[30.86-64.44]

[0.59-59.71]

[-342.2-1110.8]

Borderline tumors

4772

84.3

39.6

30000

[median/95% CI]

[-2551.87-12095.87]

[30.34-138.26]

[-8.83-88.03]

-

Benign epithelial

2150

56.850

24.4

3872

/gonadal tumors

[-5878.85-10178.85]

[43.64-70.07]

[-23.97-72.76]

[-29543.1-37287.05]

[median/95% CI]

    

Myomas

4822

58.3

90.1

-

[median/95% CI]

[-2435-12079.64]

[36.79-79.81]

[-841.26-1021.46]

-

Inflammation

498.6

65.7

113.25

-

[median/95% CI]

[-573.25-1570-45]

[57.09-74.31]

[-136.41-362.91]

-

Cirrhosis

675.95

112.6

743.75

-

[median/95% CI]

[-113.78-1465.68]

[28.17-196.83]

[-998-2458.5]

-